西沙必利(cisapride)制造商已决定停止使用大剂量西沙必利(20mg)片剂,并要求服用该药的所有患者在治疗前和治疗期间须监测肾功能和心电图,且每3个月作跟踪检查。因其易致心律失常,故仅限于胃轻瘫或严重的胃食管返流的患者在其它药物治疗无效时应用。西沙必利20mg片剂停止使用@ Manufacturers of cisapride have decided to discontinue use of high-dose cisapride (20 mg) tablets and require that all patients taking the drug be monitored for renal function and electrocardiogram before and during treatment, and every 3 months Track check. Because of its pro-arrhythmogenic effect, patients with gastroparesis or severe gastroesophageal reflux should be used when other medical treatments are ineffective. Cisapride 20mg tablets stop using @